HER‐2 receptor expression, localization, and activation in colorectal cancer cell lines and human tumors

No abstract is available for this paper.

• Publication year

  2004

• Venue

  International Journal of Cancer

• Publication date

  2004-02-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.11599PMID 14696118
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of erbB/HER receptors, heregulin and p38 in primary breast cancer using quantitative immunohistochemistry

  2009cited by this paper
• Her-2/neu as a Predictive Marker of Response to Breast Cancer Therapy

  2004cited by this paper
• In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors

  2004cited by this paper
• Trafficking of the ErbB receptors and its influence on signaling.

  2003cited by this paper
• Evaluation of HER-2/neu oncogene status in breast tumors on tissue microarrays.

  2003cited by this paper
• Modulation of growth factor receptor expression and function by integrins in colon cancer cells

  2003cited by this paper
• HER 2/neu expression and gene amplification in colon cancer

  2003cited by this paper
• Cancer Statistics, 2003

  2003cited by this paper
• c-erbB-2 is not a major factor in the development of colorectal cancer

  2002cited by this paper
• Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer.

  2002cited by this paper
• Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases.

  2002cited by this paper
• Autocrine heregulin generates growth factor independence and blocks apoptosis in colon cancer cells

  2002cited by this paper
• Non-small cell lung cancer clinical trials with trastuzumab: their foundation and preliminary results.

  2002cited by this paper
• Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.

  2002cited by this paper
• c‐erbB‐2 Expression in small‐cell lung cancer is associated with poor prognosis

  2001cited by this paper
• The HER-2/neu Oncogene in Tumors of the Gastrointestinal Tract

  2001cited by this paper
• Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

  2001cited by this paper
• C-erbB-2 Oncoprotein in Gastric Carcinoma: Correlation with Clinical Stage and Prognosis

  2001cited by this paper
• Tumour markers in breast carcinoma correlate with grade rather than with invasiveness

  2001cited by this paper
• Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth.

  2001cited by this paper
• Immunoelectron microscopical identification of the c-erbB-2 oncoprotein in patients with laryngeal squamous cell carcinoma.

  2000cited by this paper
• The ErbB signaling network: receptor heterodimerization in development and cancer

  2000cited by this paper
• The colon and rectum.

  2000cited by this paper
• Cell signaling by receptor tyrosine kinases.

  2000cited by this paper
• Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancer.

  2000cited by this paper
• Telomerase reverse transcriptase expression is increased early in the Barrett’s metaplasia, dysplasia, adenocarcinoma sequence

  2000cited by this paper
• Utility of c-crbB-2 Expression in Tissue and Sera of Ovarian Cancer Patients

  2000cited by this paper
• Clinicopathological significance of erbB-2 expression in colorectal carcinoma.

  1999cited by this paper
• ErbB-2 Amplification Inhibits Down-regulation and Induces Constitutive Activation of Both ErbB-2 and Epidermal Growth Factor Receptors*

  1999cited by this paper
• Prognostic value of immunohistochemical expression of the c‐erbB‐2 oncoprotein in metastasic prostate cancer

  1999cited by this paper
• Protein markers in colorectal cancer: predictors of liver metastasis.

  1999cited by this paper
• Protein Markers in Colorectal Cancer

  1999cited by this paper
• Increased expression of c-erbB-2 in hormone-dependent breast cancer cells inhibits cell growth and induces differentiation

  1998cited by this paper
• Immunohistochemical Study of c-erbB-2 Protein in Colorectal Cancer and the Correlation with Patient Survival

  1998cited by this paper
• Active signaling by Neu in transgenic mice

  1998cited by this paper
• ErbB Tyrosine Kinases and the Two Neuregulin Families Constitute a Ligand-Receptor Network

  1998cited by this paper
• Loss of p21WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers.

  1998cited by this paper
• Cytoplasmic staining of c‐erbB‐2 is not associated with the presence of detectable c‐erbB‐2 mRNA in breast cancer specimens

  1998cited by this paper
• erbB-2 oncoprotein expression in breast carcinoma. Poor prognosis associated with high degree of cytoplasmic positivity using CB-11 antibody.

  1997cited by this paper
• ErbB‐2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

  1997cited by this paper
• The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer.

  1997cited by this paper
• Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

  1997cited by this paper
• Histological grade in invasive ductal carcinoma of breast correlates with the proliferative activity evaluated by BrdU: An immunohistochemical study including correlations with p53, c‐erbB‐2 and estrogen receptor status

  1996cited by this paper
• Functional assay for HER-2/neu demonstrates active signalling in a minority of HER-2/neu-overexpressing invasive human breast tumours.

  1996cited by this paper
• A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

  1996cited by this paper
• Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.

  1996cited by this paper
• Overexpression of her-2/neu in human prostate cancer and benign hyperplasia.

  1996cited by this paper
• p185erbB2 binds to GRP94 in vivo. Dissociation of the p185erbB2/GRP94 heterocomplex by benzoquinone ansamycins precedes depletion of p185erbB2.

  1996cited by this paper
• Amplification and over-expression of erbB-2 oncogene in primary human breast tumors

  1996cited by this paper
• A novel method for real time quantitative RT-PCR.

  1996cited by this paper
• Polyubiquitination and Proteasomal Degradation of the p185c-erbB-2 Receptor Protein-tyrosine Kinase Induced by Geldanamycin*

  1996cited by this paper
• Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.

  1995cited by this paper
• Localized adenocarcinoma of the lung: oncogene expression of erbB-2 and p53 in 150 patients.

  1995cited by this paper
• Significance of immunohistochemical c-erbB-2 product localization pattern for prognosis of primary human breast cancer.

  1994cited by this paper
• A single autophosphorylation site confers oncogenicity to the Neu/ErbB‐2 receptor and enables coupling to the MAP kinase pathway.

  1994cited by this paper
• Signaling by Receptor Tyrosine Kinases

  1993cited by this paper
• Double immunostaining for c-erbB-2 and p53 in human stomach cancer cells.

  1993cited by this paper
• Staging of cancer of the colon and rectum

  1992cited by this paper
• Expression of HER‐2/neu in renal‐cell carcinoma. Correlation with histologic subtypes and differentiation

  1992cited by this paper
• erbB-2 autophosphorylation is required for mitogenic action and high-affinity substrate coupling.

  1992cited by this paper
• A ligand for the erbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells.

  1992cited by this paper
• The transforming potential of the c-erbB-2 protein is regulated by its autophosphorylation at the carboxyl-terminal domain

  1991cited by this paper
• The selective counterstaining of the plasma membrane improves the immunoelectron microscopic detection of neu protein at the cell border.

  1990cited by this paper
• A Pathological Study of Nephroblastoma with Congenital Aniridia

  1990cited by this paper
• The subcellular localization of the neu protein in human normal and neoplastic cells

  1989cited by this paper
• Cancer statistics

  1989cited by this paper
• Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

  1989cited by this paper
• Overexpression of the EGF receptor‐related proto‐oncogene erbB‐2 in human mammary tumor cell lines by different molecular mechanisms.

  1987cited by this paper
• Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

  1987cited by this paper
• Dome formation by a human colonic adenocarcinoma cell line (HCA-7).

  1985cited by this paper

• Complete preclinical evaluation of the novel antibody mimetic Nanofitin-IRDye800CW for diverse non-invasive diagnostic applications in the management of HER-2 positive tumors

  2025cites this paper
• Individual-Based Modeling of Microbial Communities Integrating Genetic Mechanisms: A Case Study of LuxS-Mediated Quorum Sensing in Salmonella Typhimurium

  2025cites this paper
• C-ERB B2 EXPRESSION IN COLORECTAL CARCINOMA; ITS RELATIONSHIP WITH TUMOR GRADE AND OTHER PROGNOSTIC FACTORS

  2024influential citation
• Study of gastrointestinal neoplasms, histopathologic and immunohistochemical correlation using HER-2/NEU, CK-7 and CK-20

  2023cites this paper
• Becker Digital

  2023cites this paper
• Expression of HER2/neu in gastric adenocarcinoma and its correlation with serum HER2/neu level and E-cadherin expression

  2022cites this paper
• A Novel miRNA Located in the HER2 Gene Shows an Inhibitory Effect on Wnt Signaling and Cell Cycle Progression

  2022cites this paper
• Clinicopathological and prognostic significance of HER2 status in surgically resected colorectal liver metastases

  2022cites this paper
• One-pot colorimetric detection of molecules based on proximity proteolysis reaction.

  2021cites this paper
• Localization of Organelle Proteins by Isotope Tagging: Current status and potential applications in drug discovery research.

  2021cites this paper
• Soluble Cytoplasmic Expression and Purification of Immunotoxin HER2(scFv)-PE24B as a Maltose Binding Protein Fusion

  2021cites this paper
• Spatiotemporally Differential Expression of HER (Human Epithelial Growth Factor Receptor)-2 with Sexual Dimorphism in Submandibular Gland of Mice

  2021cites this paper
• Assessment of immunohistochemical Expression of HER2\Neu and BRCA1 in Colorectal Tumors and it's Correlation with Clinicopathological Variables

  2020cites this paper
• Prospective Study

  2020cites this paper
• Trichothecin inhibits invasion and metastasis of colon carcinoma associating with SCD-1-mediated metabolite alteration.

  2020cites this paper
• Differential Expression of HER2 and SKP2 in Benign and Malignant Colorectal Lesions

  2020cites this paper
• An overview of the role of interleukin-8 in colorectal cancer.

  2020cites this paper
• Frequency of overexpression of Her2/neu in colorectal adenocarcinomas– A hospital based cross-sectional study

  2020cites this paper
• Histopathological spectrum of lower Gastro-intestinal colonoscopic biopsy lesion with special reference to Her-2/neu expression in carcinoma colon

  2020cites this paper
• Detection of ERBB2 Amplification by Next-Generation Sequencing Predicts HER2 Expression in Colorectal Carcinoma.

  2019cites this paper
• Significance of HER2 protein expression and HER2 gene amplification in colorectal adenocarcinomas

  2019cites this paper
• Prevalence, prognosis and predictive status of HER2 amplification in anti-EGFR-resistant metastatic colorectal cancer

  2019cites this paper
• Caveolin-1 mediates cellular distribution of HER2 and affects trastuzumab binding and therapeutic efficacy

  2018cites this paper
• Membranous or Cytoplasmic HER2 Expression in Colorectal Carcinoma: Evaluation of Prognostic Value Using Both IHC & BDISH

  2018cites this paper
• Cancer–adipose tissue interaction and fluid flow synergistically modulate cell kinetics, HER2 expression, and trastuzumab efficacy in gastric cancer

  2018cites this paper
• Prognostic Significance of HER2 and MLH1Protein Expression in Colorectal Cancer

  2018cites this paper
• CORRELATION OF HER2/NEU EXPRESSION AND HISTOPATHOLOGICAL GRADING AND STAGING OF COLORECTAL CARCINOMAS

  2017cites this paper
• HER2/neu Expression in Colorectal Cancers

  2017cites this paper
• Design and Synthesis of Near-Infrared Peptide for in Vivo Molecular Imaging of HER2.

  2016cites this paper
• CYTOPLASMIC EXPRESSION OF HER2 IN GASTRIC ADENOCARCINOMA: AN UNUSUAL FINDING

  2016influential citation
• Frequency of Her2/neu expression in colorectal adenocarcinoma: a study from developing South Asian Country

  2016cites this paper
• HER2 expression variability between primary gastric cancers and corresponding lymph node metastases.

  2015cites this paper
• HER2: An emerging biomarker in non-breast and non-gastric cancers

  2015cites this paper
• HER-2 and HER-3 expression in liver metastases of patients with colorectal cancer

  2015cites this paper
• Survey of HER2-neu Expression in Colonic Adenocarcinoma in the West of Iran.

  2015cites this paper
• Significance of human epidermal growth factor receptor 2 expression in colorectal cancer

  2014cites this paper
• Part 2 : Distribution of HER 2 / neu overexpression and gene amplification by organ , tumor site and histology

  2014cites this paper
• Immunohistochemical results of HER2/neu protein expression assessed by rabbit monoclonal antibodies SP3 and 4B5 in colorectal carcinomas.

  2014cites this paper
• Frequency of HER2/neu overexpression in adenocarcinoma of the gastrointestinal system.

  2014cites this paper
• HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology

  2014cites this paper
• THE ROLE OF HER-2 CYTOPLASMIC RECEPTOR OVEREXPRESSION IN COLORECTAL CANCER

  2014cites this paper
• EGFR and HER2 inhibition in pancreatic cancer

  2013cites this paper
• The expression of HER-2/neu gene in colon cancer tissues and its clinical significance

  2013cites this paper
• Effects of ectopic HER-2/neu gene expression on the COX-2/PGE2/P450arom signaling pathway in endometrial carcinoma cells: HER-2/neu gene expression in endometrial carcinoma cells

  2013cites this paper
• Clinical role of HER-2/neu expression in colorectal cancer.

  2013cites this paper
• Cytoplasmic Overexpression of HER2: a Key Factor in Colorectal Cancer

  2013cites this paper
• Over-expression of Her-2 in colorectal cancer tissue, but not in serum, constitutes an independent worse prognostic factor

  2013cites this paper
• HER-2 Expression in Brain Metastases from Colorectal Cancer and Corresponding Primary Tumors: A Case Cohort Series

  2013cites this paper
• Meprinα Transactivates the Epidermal Growth Factor Receptor (EGFR) via Ligand Shedding, thereby Enhancing Colorectal Cancer Cell Proliferation and Migration*

  2012cites this paper
• The relationship between the stromal mast cell number, microvessel density, c-erbB-2 staining and survival and prognostic factors in colorectal carcinoma.

  2012cites this paper
• Panitumumab in combination with cytotoxic chemotherapy for the treatment of metastatic colorectal carcinoma.

  2012cites this paper
• Clinicopathological evaluation of fatty acid synthase, ErbB2, and Ki-67 expression in squamous cell carcinoma of the tongue: a retrospective study

  2012cites this paper
• Association of human epidermal growth factor receptor-2 expression and clinicopathological findings in patients with colorectal cancer.

  2012cites this paper
• The Atypical Histone MacroH2A1.2 Interacts with HER-2 Protein in Cancer Cells*

  2012cites this paper
• The Mediterranean diet: effects on proteins that mediate fatty acid metabolism in the colon.

  2011cites this paper
• Expression of HER2 in Colorectal Cancer Does Not Correlate with Prognosis

  2011cites this paper
• Heterogeneity in primary tumors and corresponding metastases: could it provide us with any hints to personalize cancer therapy?

  2011cites this paper
• Human epidermal growth factor receptor (HER 2)/neu expression and gene amplification in colorectal cancer

  2011cites this paper
• Expression of Her-2/neu in Colon Carcinoma and Its Correlation with the Histological Grades and the Lymph Nodes Status

  2011cites this paper
• [Specificity of action of anticancer agents].

  2011cites this paper
• The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal Cancer

  2011cites this paper
• Correlation of HER-2/neu Oncogene Expression And Grades of Transitional Cell Carcinoma of Bladder

  2011cites this paper
• Colorectal cancer in review: the role of the EGFR pathway

  2010cites this paper
• Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?

  2009cites this paper
• Human epidermal growth factor receptor-2 family in colorectal adenocarcinoma: correlation with survival and clinicopathological findings

  2009cites this paper
• Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance

  2009cites this paper
• A simple biological imaging system for detecting viable human circulating tumor cells.

  2009cites this paper
• Safety and Efficacy of Panitumumab in the Treatment of Metastatic Colorectal Cancer

  2009cites this paper
• Clinical utility of type 1 growth factor receptor expression in colon cancer.

  2008cites this paper
• ErbB2 and fatty acid synthase (FAS) expression in 102 squamous cell carcinomas of the tongue: correlation with clinical outcomes.

  2008cites this paper
• [Target selectivity of anticancer drugs].

  2008cites this paper
• High-risk HPV/ErbB-2 interaction on E-cadherin/catenin regulation in human carcinogenesis.

  2008cites this paper
• Inhibition of ErbB2 and Thymidylate Synthase by a Multi-Targeted Small-Interfering RNA in Human Breast Cancer Cell Lines

  2008cites this paper
• Suppression of cancer invasiveness by dietary compounds.

  2008cites this paper
• Different matrix micro-environments in colon cancer and diverticular disease

  2007cites this paper
• Circulating tumor cells (CTC) detection: clinical impact and future directions.

  2007cites this paper
• Her-2 Protein Expression, Cellular Localization, and Gene Amplification in Colorectal Carcinoma

  2007cites this paper
• Anti-EGFR and ErbB-2 antibodies attenuate cyclooxygenase-2 expression and cooperatively inhibit survival of human colon cancer cells.

  2007cites this paper
• Mucin expression profile in pancreatic cancer and the precursor lesions.

  2007cites this paper
• Cytoplasmic Expression of c-erb-B2 in Endometrial Carcinomas

  2007cites this paper
• MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma.

  2007cites this paper
• C-erbb-2 correlación con pronóstico y sobrevida en el denocarcinoma de colon

  2007cites this paper
• Epidermal growth factor receptor signaling is required for microadenoma formation in the mouse azoxymethane model of colonic carcinogenesis.

  2007cites this paper
• HER 2/neu protein expression in colorectal cancer

  2006cites this paper
• CHAPTER 7 – Growth Factors in the Gastrointestinal Tract

  2006cites this paper
• OK432-activated natural killer cells enhanced trastuzumab (Herceptin)-mediated antibody-dependent cellular cytotoxicity in patients with advanced cancer.

  2006cites this paper
• Growth Factors in the Gastrointestinal Tract

  2006cites this paper
• Epidermal growth factor receptor signaling is up-regulated in human colonic aberrant crypt foci.

  2006cites this paper
• Simultaneous estimation of c-erbB2 and p53 proteins - lack of clinical relevancy in colorectal cancer

  2006influential citation
• Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas

  2006cites this paper
• Colon cancer and the immune system: the role of tumor invading T cells.

  2006cites this paper
• HER2/NEN EXPRESSION IN COLON ADENOCARCINOMA AND ITS CORRELATION WITH CLINICOPATHOLOGIC VARIABLES

  2006cites this paper
• Clinicopathologic Significance of EGFR and Her‐2/neu in Colorectal Adenocarcinomas

  2006cites this paper
• Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan.

  2005cites this paper
• MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas

  2005cites this paper
• Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells.

  2005cites this paper
• Mechanisms responsible for ERBB2 gene overexpression in human breast and non-breast cancer cells. The role of AP-2 transcription factors

  2005cites this paper
• Supportive care : Quality of life assessment 393

  2004cites this paper